Search

Search results

115 results found

Fall 2019 Issue of Harvard Otolaryngology Now Available

We are pleased to present our latest issue of Harvard Otolaryngology. Highlights include: Hidden Hearing Loss: A 10-Year Journey: A decade after the discovery of cochlear synaptopathy, scientists uncover a new potential cause Is Tongue-Tie Surgery Always Necessary: New research questions whether too...

Dr. David H. Jung Presented Norman Knight Award

David H. Jung, MD, PhD, FACS, a neurotologic surgeon at Mass Eye and Ear, has been named the recipient of the Norman Knight Leadership Development Award. The award was endowed by Norman Knight, a self-made broadcast pioneer and media mogul who has been a thoughtful champion of Mass Eye and Ear for...

Resident Roy Xiao, MD, MS Awarded CORE Grant

Roy Xiao, MD, MS, a PGY-3 resident in the Harvard Combined Residency Program, was recently awarded a Centralized Otolaryngology Research Effort (CORE) grant by the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF). Dr. Xiao, who completed the Medical Research Scholars...

Dr. Dunia Abdul-Aziz receives the 2017 Yellen Young Investigator Award

Neurotology fellow Dr. Dunia Abdul-Aziz is the recipient of the 2017 Yellen Young Investigator Award. Long-time Mass. Eye and Ear Trustees, Patricia and Barry Yellen, have been giving annual gifts toward this endowed award to support the research of trainees studying hearing and hearing loss since...

Mifepristone May Halt Growth of Intracranial Tumor That Causes Hearing Loss

Boston, Mass. — Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and...